Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|August 26, 2022
Solid-Organ Transplantation From Deceased and Living Donors With Cancer or a History of CancerOzden Altundag
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|July 22, 2022
Recent Advances in Systemic Therapy for Hepatocellular CarcinomaOzden Altundag
Medical Hypotheses|August 25, 2004
DNA methylation inhibitor, procainamide, may decrease the tamoxifen resistance by inducing overexpression of the estrogen receptor beta in breast cancer patientsOzden Altundag, Kadri Altundag, Mehmet Gunduz
Immunotherapy|November 5, 2025
Simulating a virtual tumor board with large language models: a pilot study in NSCLC patients receiving immunotherapyRashad Ismayilov, Ozden Altundag, Zafer Akcali
Expert Opinion on Emerging Drugs|September 11, 2010
Emerging drugs in endometrial cancersOzden Altundag, Polat Dursun, Ali Ayhan
Medical Hypotheses|July 9, 2004
Adjuvant targeted therapy with trastuzumab may decrease metastatic capacity in specific group of oropharyngeal cancer patients: downregulation of E-cadherin-catenin complex by cooperative effect of erbB-2 and human papillomavirus type 16 E6/E7 protooncogenesOzden Altundag, Kadri Altundag, Paolo Morandi, et al.
Medical Hypotheses|October 19, 2004
Possible interaction between activator protein-1 and proto-oncogene B-cell lymphoma gene 6 in breast cancer patients resistant to tamoxifenKadri Altundag, Ozden Altundag, Mehmet Gunduz, et al.
Indian Journal of Cancer|December 13, 2023
Brain metastasis of hepatocellular carcinoma- single center experienceSamed Rahatli, Arzu Oguz, Zohrab Abduyev, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|June 4, 2020
Vismodegib Experience in a Renal Transplant Patient With Basal Cell CarcinomaSamed Rahatli, Arzu Oguz, Ozden Altundag, et al.
Tumori|June 30, 2026
Driver vs. passenger: Primary resistance to larotrectinib in synovial sarcoma harboring concurrent SS18 rearrangement and PDE3A-NTRK2 fusionRashad Ismayilov, Buge Oz, Arzu Oguz, et al.
Pageof 5